Bioptik Technology (4161) — Cash Flow-to-Debt Ratio
Bioptik Technology (4161) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of NT$53.21 Million could theoretically repay 0% of its total liabilities (NT$597.14 Million) in one year. See free cash flow generation of Bioptik Technology to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bioptik Technology Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Bioptik Technology across 9 annual periods. Also explore net asset growth rate of Bioptik Technology to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bioptik Technology (2017–2025)
Year-by-year debt coverage analysis for Bioptik Technology. For market capitalisation and broader financial context, see 4161 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | NT$59.99 Million | NT$597.14 Million | ▼ -63.2% |
| 2024 | 0.27x | NT$158.82 Million | NT$582.47 Million | ▼ -10.8% |
| 2023 | 0.31x | NT$205.95 Million | NT$673.56 Million | ▲ +342.9% |
| 2022 | 0.07x | NT$55.06 Million | NT$797.40 Million | ▲ +239.2% |
| 2021 | -0.05x | NT$-41.15 Million | NT$829.38 Million | ▼ -657.2% |
| 2020 | 0.01x | NT$6.57 Million | NT$738.10 Million | ▼ -82.9% |
| 2019 | 0.05x | NT$41.03 Million | NT$786.05 Million | ▼ -1.1% |
| 2018 | 0.05x | NT$41.83 Million | NT$792.07 Million | ▲ +225.0% |
| 2017 | 0.02x | NT$11.02 Million | NT$678.08 Million | — |